Parainfluenza Virus Infection
📧 Sign up to get email alerts when something new happens for Parainfluenza Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) [Phase 2]
Phase 2 clinical trial update for PUL-042 in patients with parainfluenza virus, human metapneumovirus, or respiratory syncytial virus infect…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older [Phase 1]
A Phase 1 study of a vaccine candidate against respiratory syncytial virus, metapneumovirus, and parainfluenza virus type 3 in adults aged 6…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age. [Phase 1]
Sanofi completed a Phase 1 clinical trial evaluating the safety and immunogenicity of vaccines targeting influenza, respiratory syncytial vi…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults [Phase 1]
Phase 1 clinical trial update for VXB-251, a trivalent vaccine targeting RSV, human metapneumovirus, and parainfluenza virus type 3, studied…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults [Phase 1]
This document describes an early-phase, first-in-human safety and immunogenicity study of the vaccine candidates SCB-1022 and SCB-1033 in he…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens
A study evaluating a single-use point-of-care diagnostic device for detecting multiple respiratory pathogens was terminated, with results po…
-
CLINICAL_TRIALS other · 2024-11-20Clinical Trial Update: Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study [Phase 3]
Phase 3 randomized trial of DAS181 for lower respiratory tract Parainfluenza infection in immunocompromised subjects, with a sub-study for C…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant [Phase 1, Phase 2]
A Phase 1/2 study of ALVR106 in patients with respiratory tract viral infections after hematopoietic cell or solid organ transplantation was…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia [NA]
Clinical trial registry entry for evaluating the LIAISON NES diagnostic assay for Influenza A/B, RSV, and COVID-19 in symptomatic patients i…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection [Phase 2]
This Phase 2 open-label study evaluated DAS181 delivered by dry powder inhaler or nebulized formulation in immunocompromised patients with p…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Specific Respiratory Infections as Triggers of Acute Medical Events
A completed clinical trial update examining whether specific respiratory infections act as triggers for acute medical events, including card…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children [Phase 1]
A Phase 1 trial evaluating the safety and immunogenicity of a Human Parainfluenza Virus Type 3 vaccine in infants and children has completed…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine [Phase 1]
Phase 1 study evaluating the safety and immune response of a recombinant live-attenuated parainfluenza virus type 1 vaccine.
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children [Phase 1]
This Phase 1 trial assessed the safety and immune response of a recombinant live attenuated Parainfluenza Type 3 vaccine in healthy infants …
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Collection and Testing of Respiratory Samples
A completed clinical trial assessing collection and testing of respiratory samples using the QIAGEN ResPlex II Advanced Panel and Artus Infl…
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age [Phase 1]
Phase 1 safety and tolerability study of MEDI-534 in infants 6 to <24 months with viral respiratory infections, including RSV and parainflue…